Posted on by

Biogen’s stock rises 4% after company releases new data on late-stage Alzheimer’s drug – CNBC

  1. Biogen’s stock rises 4% after company releases new data on late-stage Alzheimer’s drug  CNBC
  2. New details emerge on drug that may slow Alzheimer’s disease  NBCNews.com
  3. Biogen Resumes Alzheimer’s Studies to Offer Controversial Drug  Bloomberg
  4. Data on Biogen’s Alzheimer’s drug raise more questions than answers  STAT
  5. As Alzheimer’s Conference Kicks Off, All Eyes Are on Biogen’s Drug  Xconomy
  6. View full coverage on Google News